Social Media-based Vaccine Confidence and Hesitancy Monitoring
NCT05442762 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2022-07-05
Summary
History and scientific evidence show that it is critical to maintain public trust and confidence in vaccination. Any crisis in confidence has the potential to cause significant disruption and a detrimental impact on vaccination. Vaccine hesitancy is a complex and context-specific issue that varies across time, place, and vaccines. It has been cited by World Health Organization(WHO) as one of the top ten threats to global health in 2019. Coronavirus disease(COVID-19) pandemic may change public confidence in vaccines. Therefore, it is necessary to establish a surveillance system to monitor vaccine confidence and hesitancy in real time.
To date, a growing body of literature has used social media platforms such as Twitter and weico for public health research. Large amounts of real time data posted on social media platforms can be used to quickly identify the public's attitudes on vaccines, as a way to support health communication and health promotion, messaging. However, textual data on social media is difficult to be analyzed. Recent progress in machine learning makes it possible to automatically analyze textual data on social media in real time.
In this study, the investigators will establish a social media surveillance and analysis platform on vaccines, develop a series of machine learning models to monitor vaccine confidence and early detect emerging vaccine-related risks, and assess public communication around vaccines. The investigators will assess the temporal and spatial distribution of vaccine confidence and hesitancy globally using Twitter data and in China using weico data, for all vaccines and Human Papilloma Virus(HPV) vaccine, respectively. Our study will guide the design of effective health communication strategies to improve vaccine confidence.
Conditions
- Social Medium
- Data Collection
- Patient Acceptance of Health Care
- Immunization Programs
- Vaccination Refusal
- Information Dissemination
- Machine Learning
- Internet-Based Intervention
Sponsors & Collaborators
- collaborator INDUSTRY
-
Fudan University
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-03-01
- Primary Completion
- 2022-06-01
- Completion
- 2022-06-24
More Related Trials
-
To Evaluate the Safety and Primary Immunogenicity of Cell-free (Three-component) Combination Vaccine for Phase I Immunogenicity in Children and Infants
NCT05189548 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Phase 3 Study of A Group A, C Polysaccharide Meningococcal and Type b Haemophilus Influenzal Conjugate Vaccine
NCT01580033 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity and Safety of A Group A, C Polysaccharide Meningococcal and Type b Haemophilus Influenzal Conjugate Vaccine in Infants and Children
NCT01428908 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Immunization Schedules of Inactivated Hepatitis A Vaccine and Combined Hepatitis A and Hepatitis B Vaccine
NCT02445703 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Immunogenicity of an Inactivated EV71 Vaccine in Infants
NCT01421121 ·Status: COMPLETED ·Phase: PHASE2
-
Chatbot-based Intervention to Promote Vaccine Acceptance in Varansi, India
NCT05994820 ·Status: COMPLETED ·Phase: NA
-
A Phase II, Safety and Efficacy Study of Inactivated EV 71 Vaccine (Human Diploid Cell, KMB-17) in Chinese Infants
NCT01512706 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Immunogenicity of DTaP-IPV/Hib Pentavalent Vaccine in Chinese 2-month-old Infants
NCT06605755 ·Status: RECRUITING ·Phase: NA
-
Postmarketing Surveillance Study for IMOJEV® in Republic of Korea
NCT02933710 ·Status: COMPLETED
-
Safety and Immunogenicity of a Monovalent Conjugated Vaccine Against Haemophilus Influenzae Type b
NCT00808392 ·Status: COMPLETED ·Phase: PHASE3
-
Phase II of Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17) in Chinese Infants
NCT03133923 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Safety Study of Live Attenuated Mumps Vaccines in Junior High School Students Under 14 Years Old
NCT05145166 ·Status: COMPLETED
-
10+10+30 Infant Vaccines Communication Via Radio in Ethiopia
NCT04913714 ·Status: COMPLETED ·Phase: NA
-
Safety of A Group A, C Polysaccharide Meningococcal and Type b Haemophilus Influenzal Conjugate Vaccine in Children
NCT01406509 ·Status: COMPLETED ·Phase: PHASE1
-
A Pilot Clinical Study of PET Scanning in Evaluation of Vaccine Reactogenicity
NCT04515368 ·Status: COMPLETED ·Phase: NA
-
Assessing Knowledge, Beliefs and Attitudes Toward HPV Vaccination Among Parents in North West, Cameroon
NCT05325138 ·Status: UNKNOWN
-
Clinic Trial to Evaluate the Safety and Immunogenicity by Different Sequential Schedules of bOPV and IPV
NCT03614702 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273.214 SARS-CoV-2 (COVID-19) Vaccine in Infants
NCT05584202 ·Status: TERMINATED ·Phase: PHASE2
-
Safety and Immunogenicity Study of Live Attenuated Mumps Vaccines in Healthy Infants
NCT05065177 ·Status: COMPLETED ·Phase: PHASE3
-
Social Media as an Information, Education and Communication Tool for Rabies Prevention: An Interventional Study
NCT05702008 ·Status: COMPLETED ·Phase: NA
-
Clinical Study on Combined Immune Effect of EV71 Inactivated Vaccine
NCT03519568 ·Status: UNKNOWN ·Phase: PHASE4
-
Safety and Reactogenicity of a Monovalent Conjugated Vaccine Against Haemophilus Influenzae Type b
NCT00734565 ·Status: COMPLETED ·Phase: PHASE1
-
An Online Intervention Promoting HPV Vaccination Among Chinese MSM
NCT04815837 ·Status: COMPLETED ·Phase: NA
-
Study in Toddlers (12-18 Months) Comparing a Booster Dose of Vaxem Hib and Hiberix Vaccines for the Prevention of Haemophilus Influenzae Type b Infections in China
NCT01025544 ·Status: COMPLETED ·Phase: PHASE3
-
Studies of the Safety and Immunogenicity of a Sabin Inactivated Poliovirus Vaccine
NCT02985320 ·Status: COMPLETED ·Phase: PHASE1/PHASE2